Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04304963Completed

Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS

Role: collaborator

NCT03289897Not ApplicableCompleted

Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan

Role: collaborator

NCT04675346Completed

Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors

Role: collaborator

NCT01858246Not ApplicableCompleted

A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge

Role: lead

All 4 trials loaded